Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $97.5600 (0.02%) ($95.8000 - $99.6900) on Thu. Mar. 3, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.85% (three month average) | RSI | 75 | Latest Price | $97.5600(0.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.7% a day on average for past five trading days. | Weekly Trend | LGND advances 4.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.425% in a week (0% probabilities). VIXM(-16%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.425% (StdDev 2.85%) | Hourly BBV | 0 () | Intraday Trend | -1.5% | | | |
|
5 Day Moving Average | $95.99(1.64%) | 10 Day Moving Average | $94.25(3.51%) | 20 Day Moving Average | $92.11(5.92%) | To recent high | -12.8% | To recent low | 13.7% | Market Cap | $1.568b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |